Replies to post #203904 on Anavex Life Sciences Corp (AVXL)

[WolfofMia]

Tick-tock goes the short`s clock.

[sage4]

I thought that you were joking but that’s it. That’s da news.
I’m scratching my head. Lol

[imho]

Most excellent- “Continue the study without modification.”

This may speed up recruiting and also allow for A2-73 to be tested on younger patients. According to this link

It is generally expected that a DSMB will be utilized in the following situations:

- For some studies involving particularly vulnerable study participants (e.g., children or persons with impaired ability to consent), it may be beneficially to utilize a DSMB as an additional measure of subject protection

IMHO